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Investigation of multiphasic 3D-bioplotted scaffolds for sitespecific chondrogenic and osteogenic differentiation of human
adipose-derived stem cells for osteochondral tissue
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Abstract
Osteoarthritis is a degenerative joint disease that limits mobility of the affected joint
due to the degradation of articular cartilage and subchondral bone. The limited regenerative capacity of cartilage presents significant challenges when attempting to repair
or reverse the effects of cartilage degradation. Tissue engineered medical products
are a promising alternative to treat osteochondral degeneration due to their potential
to integrate into the patient's existing tissue. The goal of this study was to create a
scaffold that would induce site-specific osteogenic and chondrogenic differentiation
of human adipose-derived stem cells (hASC) to generate a full osteochondral implant.
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Scaffolds were fabricated using 3D-bioplotting of biodegradable polycraprolactone
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extracellular matrix (dECM) to drive site-specific hASC osteogenesis and cho-

(PCL) with either β-tricalcium phosphate (TCP) or decellularized bovine cartilage
ndrogenesis, respectively. PCL-dECM scaffolds demonstrated elevated matrix deposition and organization in scaffolds seeded with hASC as well as a reduction in
collagen I gene expression. 3D-bioplotted PCL scaffolds with 20% TCP demonstrated
elevated calcium deposition, endogenous alkaline phosphatase activity, and
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osteopontin gene expression. Osteochondral scaffolds comprised of hASC-seeded
3D-bioplotted PCL-TCP, electrospun PCL, and 3D-bioplotted PCL-dECM phases
were evaluated and demonstrated site-specific osteochondral tissue characteristics.
This technique holds great promise as cartilage morbidity is minimized since autologous cartilage harvest is not required, tissue rejection is minimized via use of an
abundant and accessible source of autologous stem cells, and biofabrication techniques allow for a precise, customizable methodology to rapidly produce the scaffold.
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I N T RO DU CT I O N

engineered bone and cartilage tissue (Hung et al., 2003; Lima et al.,
2004; Schaefer et al., 2000). A disadvantage of this method is the lack

Osteoarthritis (OA) is a degenerative joint disease that limits mobility

of mechanical integration at the junction, leading to delamination of

of the affected joint due to the degradation of articular cartilage and

the layers. One approach to avoid delamination is to develop a mono-

changes in the adjacent subchondral bone. OA has been estimated to

lithic scaffold with two phases that can be cultured as a unit to induce

affect approximately 27 million people in the United States, and the

osteogenesis and chondrogenesis simultaneously. In this method, there

prevalence is only expected to grow (Kotlarz, Gunnarsson, Fang, &

are challenges to promoting both chondrogenic and osteogenic factors

Rizzo, 2009). There are significant challenges with treating cartilage

within the same culture system (Shimomura, Moriguchi, Murawski,

and osteochondral degradation due to the limited regenerative capac-

Yoshikawa, & Nakamura, 2014), which can be addressed by introduc-

ity of articular cartilage, lack of understanding of the molecular mech-

ing biomimetic factors to the scaffold that induce either cartilage or

anisms that trigger early changes in cartilage homeostasis, and lack of

bone formation (Mellor et al., 2015; Tampieri et al., 2008). In addition

tools to detect the disease at early stages. To date, there is no cure

to biphasic systems, a few studies have attempted to achieve a graded

for OA and therapeutic treatments are limited to controlling pain and

transition zone of bone to cartilage throughout the depth of an

inflammation of the joint.

engineered osteochondral tissue (Erisken, Kalyon, & Wang, 2010; Jiang

Current clinical treatment options for cartilage repair include

et al., 2010; Kon, Mutini, et al., 2010; Kon, Delcogliano, Filardo, Fini,

autologous chondrocyte implantation (ACI), microfracture, and

et al., 2010; Kon, Delcogliano, Filardo, Pressato, et al., 2010; Tampieri

mosaicplasty (Revell & Athanasiou, 2009). ACI requires a surgical

et al., 2008) as an attempt to improve load-bearing capabilities in vivo

biopsy of the patient's healthy articular cartilage, followed by isolation

and reduce shear stresses at the biomaterial interfaces (Lu, Subramony,

and expansion of chondrocytes for several weeks in culture. A second

Boushell, & Zhang, 2010). Some of the technical and culturing chal-

surgery reintroduces the expanded chondrocytes into the defect site.

lenges include identifying the ideal cell source, optimizing growth fac-

However, this method has associated donor site morbidity and yields

tors, and signaling molecules to induce site-specific differentiation,

fibrocartilaginous tissue which is prone to degeneration (Niemeyer

inhibiting hypertrophy, and developing a simple and reliable manner to

et al., 2008). In microfracture, small holes are drilled into the defect to

manufacture scaffolds of varying size to fit a specific injury site. After

allow mesenchymal stem cells to migrate from the subchondral bone

implantation, the primary concern is blood vessel invasion into the car-

yielding new tissue formation (Yousefi, Hoque, Prasad, & Uth, 2015).

tilage region that results in endochondral ossification, and proper inte-

This technique also results in fibrocartilage formation (Gilbert, 1998),

gration with the host tissue (Nukavarapu & Dorcemus, 2013).

and therapeutic effects are only sustained for approximately 1 year

The objective of this study was to investigate the use of a single

(Yousefi et al., 2015). Mosaicplasty transfers plugs of autologous

cell source, human adipose-derived stem cells (hASC; Nordberg &

osteochondral tissue from nonweight-bearing healthy regions to

Loboa, 2015; Pittenger et al., 1999), within an integrated multi-

repair the defect. However, this method is limited by the amount of

material, multiscale triphasic 3D scaffold created using a combination

donor sites and is also associated with donor site morbidity (Getgood,

of

Brooks, Fortier, & Rushton, 2009). Because of the limitations with cur-

osteochondral tissue generation. Human ASC, which are more abun-

rent treatment options for osteochondral injury, tissue engineering

dant and accessible than human bone marrow-derived mesenchymal

approaches have become an active area of research.

stem cells (hMSC; Awad, Wickham, Leddy, Gimble, & Guilak, 2004;

3D-bioplotting

and

electrospinning

to

achieve

complete

One of the critical challenges from a clinical application perspec-

Huang, Zuk, et al., 2004; Zuk et al., 2001), are capable of both osteo-

tive is creating an engineered tissue that can mimic the complex multi-

genic and chondrogenic differentiation and can express bone and car-

phasic nature of osteochondral tissue (Atesok et al., 2014). Because of

tilage extracellular matrix (ECM) constituents (Zuk et al., 2001).

these challenges, many stem cell-based approaches for cartilage repair

Although some reports indicate that hASC chondrogenesis may be

have focused on cartilage regeneration (Getgood et al., 2009; Hillel

inferior to hMSC chondrogenesis (Huang et al., 2005; Mehlhorn et al.,

et al., 2010; Huang, Farrell, Kim, & Mauck, 2010; Huang, Farrell, &

2006), this can be overcome by alternative growth factor supplemen-

Mauck, 2010; Huang, Reuben, D'Ippolito, Schiller, & Cheung, 2004;

tation (Puetzer, Petitte, & Loboa, 2010). Our triphasic 3D scaffold

Huang, Stein, & Mauck, 2010; Lee et al., 2008; Mobasheri, Csaki,

consists of physiologically inspired chemical cues to induce site-

Clutterbuck, Rahmanzadeh, & Shakibaei, 2009; Valonen et al., 2010;

specific hASC differentiation in a manner that recapitulates the depth-

van Osch et al., 2009) instead of full osteochondral tissue regeneration

dependent properties of native osteochondral tissue. The integrated

(Deans & Elisseeff, 2009; Grayson, Bhumiratana, Grace Chao, Hung, &

3D scaffold includes a 3D-bioplotted deep layer of a composite of

Vunjak-Novakovic, 2010; Sundelacruz & Kaplan, 2009; Swieszkowski,

polycaprolactone (PCL) and β-tricalcium phosphate (TCP) to induce

Tuan, Kurzydlowski, & Hutmacher, 2007). Biphasic osteochondral scaf-

osteogenesis, a 3D-bioplotted superficial layer of PCL combined with

folds have been generated by assembling two separate scaffolds of

decellularized articular cartilage ECM (dECM) hydrogel to induce
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F I G U R E 1 Scaffold design for osteochondral tissue generation using a single cell source. In order to engineer a full osteochondral tissue using
a single cell source, site-specific chemical cues were incorporated within the scaffold to induce site-specific differentiation of hASC. To achieve
chondrogenesis, hASC were seeded within a 3D bioplotted PCL scaffold containing dECM. An electrospun layer of PCL was created and used to
recreate the tidemark. To achieve osteogenesis, hASC were seeded within a 3D bioplotted scaffold comprised of 80% PCL and 20% TCP. Full
composite scaffold shown on top right (scale bar = 5 mm). dECM, decellularized bovine cartilage extracellular matrix; hASC, human adiposederived stem cells; PCL, polycraprolactone; TCP, β-tricalcium phosphate
chondrogenesis, and an intermediate electrospun layer of PCL to

0.1M HCl. Four milliliter of this solution was added to 100 mg of carti-

mimic the native tidemark of osteochondral tissue to separate the

lage dECM powder. The ECM was digested in the pepsin solution for

two phases and potentially prevent blood vessel invasion into the car-

48 hr. Next, 400 μl of 1M NaOH was added to the solution in order to

tilage layer in vivo (Figure 1).

bring the pH to 7.4. Finally, 489 μl of 10X PBS was added to the solution
to make the concentrations of NaOH, HCl, and PBS equal to each other.
The final concentration of the gel was calculated to be 20.5 mg/ml.

2

MATERIALS AND METHODS

|

We first conducted analyses of hASC osteogenesis and cho-

2.3

|

Proteomic analysis of decellularized ECM

ndrogenesis on separate phases of 3D-bioplotted PCL-TCP and PCLdECM scaffolds, respectively, and then assessed the site-specific

Proteins were extracted using RIPA buffer protocol (Millipore, Biller-

hASC differentiation characteristics of integrated multimaterial tri-

ica, MA). Protein concentrations were determined using a BCA protein

phasic scaffolds resembling full thickness osteochondral tissue.

assay (Thermo Fisher Scientific, Waltham, MA). A volume of 20 μg of
total protein from each sample was digested in solution with Trypsin/
Lys C mix (Promega) following the manufacturer's instructions. Briefly,

2.1

|

Preparation of PCL-TCP composite

protein samples were precipitated with cold acetone and dissolved in
8M urea solution. After reduction with dithiothreitol and alkylation

The PCL-TCP composite (80–20% by weight) used for 3D-bioplotting

with iodoacetamide, samples were diluted with 50 mM Tris–HCl

of the osteogenic scaffold phase was created by mixing the appropriate

pH 8.0, to reduce urea concentration to 1M. Trypsin/Lys C Mix was

proportion of PCL (Mn: 80,000, ~3 mm pellets; Sigma-Aldrich, St. Louis,

added at a 20:1 protein: protease ratio (wt/wt). Samples were

MO) and TCP (Riedel-de-Haën AG, Seelze, Germany), and heating the

digested overnight at 37 C. Digestion was terminated with

mixture at 180 C for 60 min with intermittent stirring in a temperature-

trifluoroacetic acid. Resulting peptide mixtures were cleaned using a

controlled oven until a homogeneous, single phase mix was obtained.

C18 reverse-phase spin column (Thermo Fisher Scientific), dried under
vacuum, and reconstituted in 5% acetonitrile, 0.1% formic acid in
water for LC–MS/MS analysis.

2.2

|

Preparation of decellularized ECM hydrogel

LC–MS/MS analysis of peptides was conducted on a Velos Pro
Dual-Pressure Linear Ion Trap mass spectrometer equipped with a nano

Decellularized ECM derived from bovine hooves (Micro Summit Pro-

electrospray ionization source and coupled with an Easy-nLC II nano LC

cessors, Micro, NC) was used in a hydrogel form as a constituent of

system (Thermo Fisher Scientific). A volume of 5 μl of peptide mixture

the 3D-bioplotted scaffolds for the chondrogenic phase. Cartilage was

was loaded onto a C18 reverse-phase column (10 cm x 75 μm, 3 μm,

harvested from fresh hooves and decellularized by suspending in a

120 Å). Each sample was analyzed three times. A linear gradient with two

solution of deionized water and 0.5% penicillin/streptomycin, and

mobile phases (A: 5% acetonitrile, 0.1% formic acid, 94.9% water, 0; B:

mixing for 24 hr. The decellularized cartilage was then frozen in 1X

80% acetonitrile, 0.1% formic acid, 19.9% water) at a flow rate of 300 nl/

phosphate buffered saline (PBS) and lyophilized for 24 hr. Finally, the

min was used to separate peptide mixtures. The gradient began at 0% B,

lyophilized cartilage was pulverized in a mill using a number 40 size

increased linearly to 50% B over 180 min and then to 100% B over

mesh to obtain the decellularized cartilage ECM powder.

16 min, and maintained at this percentage for 14 min as a washing step.
of

Eluted peptides were ionized in a nano ESI source with a spray voltage of

25 mg/ml. The dECM was digested in a 2 mg/ml solution of pepsin in

2.2 kV. Full scan MS spectra were acquired from m/z 300 to 2000.

ECM

gels

were

prepared

at

an

initial

concentration
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Collision-induced dissociation was used to fragment the precursor ions.

(Table 1) in VisualMachines. A total of 6.8 g of material (80% PCL-20%

MS/MS spectra were acquired in the data-dependent acquisition mode

TCP composite for osteogenic scaffolds; 100% PCL for chondrogenic

for the 10 most abundant precursor ions in the preceding full MS scan.

scaffolds) was preheated in the high temperature cartridge and the scaf-

Peptide spectral matching and protein identification were

folds 3D-bioplotted, one at a time. Postfabrication, all scaffolds were

achieved by database search using Sequest HT algorithms in Prote-

weighed (AR2140 digital balance, Ohaus Corp., Parsippany, NJ) and

ome Discoverer 1.4 (Thermo Fisher Scientific). Raw spectrum data

characterized for strand width and interstrand spacing (×50 magnifica-

were used to search against the UniProtKB/Swiss-Prot protein data-

tion, KH-7700 microscope, Hirox, Hackensack, NJ). From each scaffold,

base for bovine. Main search parameters included: trypsin, maximum

for each dimension metric, measurements were taken at eight random

missed cleavage site of two, precursor mass tolerance of 1.5 Da, frag-

locations. All scaffolds were sterilized for 30 min in 70% ethanol, and

ment mass tolerance of 0.8 Da, and variable modification of oxida-

washed three times with sterile ×1 PBS and once with complete growth

tion/hydroxylation of methionine, proline, and lysine (+15.995 Da).

medium (CGM, defined below).

Decoy database search was performed to calculate false discovery

To prepare the PCL-dECM scaffolds for chondrogenic analyses,

rate (FDR). Proteins containing one or more peptides with FDR ≤ 0.05

200 μl of the decellularized bovine cartilage ECM hydrogel (protocol

were considered positively identified and reported. Total number of

described above) was added onto each sterilized 3D-bioplotted 100%

peptide spectral matches for each protein reported by Protein Discov-

PCL scaffold. The hydrogel-infused scaffolds were placed in an incu-

erer 1.4 was used for quantification.

bator (37 C, 5% CO2) overnight to allow the gel to solidify, and were
then placed in 24-well plates prior to seeding with hASC.

2.4 | 3D-bioplotting of osteogenic and
chondrogenic scaffold phases

2.5 | Characterization of calcium release from PCLTCP scaffolds

We have previously optimized the geometry and assessed the biocompatibility of the 3D-bioplotted scaffolds used in this study (Mehendale,

PCL-TCP scaffolds were placed into separate wells in a 24-well plate

Mellor, Taylor, Loboa, & Shirwaiker, 2017; Mellor et al., 2017). Using the

(n = 3 per time point) and treated for 30 min with 70% ethanol to

methods described previously, the base computer assisted design

mimic the sterilization process used in later cell culture experiments.

models of the scaffolds were created in Solidworks (Dassault Systèmes

Ethanol treatment also increased the hydrophilicity of the scaffold for

SOLIDWORKS Corp., Waltham, MA) as discs (Ø14.5 x 2 mm) to fit the

the Ca2+ release experiments. The scaffolds were then fully sub-

individual wells of a standard 24-well culture plate. The STL file, sliced

merged in 0.5 ml of PBS and maintained in an incubator (37 C, 5%

into six layers, was positioned onto the bioplotting stage (BioplotterRP,

CO2) for the duration of the study. PBS was collected at time points

EnvisionTEC GmbH, Gladbeck, Germany). To begin scaffold fabrication

of 1, 2, 7, 14, and 28 days and stored at −25 C until assayed. A Cal-

on the 3D-Bioplotter (EnvisionTEC GmbH), the strand-pore geometry

cium LiquiColor® Assay (StanBio, Boerne, TX) was used to quantify

previously determined to be favorable for hASC (Mehendale et al.,

calcium content of each sample. Using the measured weight of the

2017) and experimentally optimized process parameters were assigned

scaffolds along with the molar mass of calcium ions (Ca2+
40.08 g•mol−1), orthophosphates (PO43−94.97 g•mol−1), and TCP

TABLE 1

Scaffold design and 3D-bioplotting parameters
PCL-TCP

Scaffold
design

PCL

Strand lay orientation
( , layer 1/2/3)

0/120/240 0/120/240

Strand width (μm)

378 ± 40

351 ± 33

Interstrand spacing (μm)

602 ± 41

632 ± 55

Weight (mg)

[Ca3(PO4)2 310.18 g•mol−1] the weight of Ca2+ doped within each
scaffold was calculated to be 11.9 μg.

2.6 | Human ASC isolation, expansion, and in vitro
culture of scaffolds

154 ± 24

118 ± 16

130

160

Preheat interval (min)

25

45

Nozzle diameter (mm)

0.4

0.4

Extrusion pressure
(N/mm2)

0.5

0.5

Nozzle speed (mm/s)

0.7

0.4

Preflow delay (s)

1

1

Premium Select, Atlanta Biologicals, Lawrenceville, GA), 200 mM L-glu-

Postflow delay (s)

0

1

tamine, and 100 IU penicillin/100 μg/ml streptomycin (Mediatech,

Wait time between
layers (s)

0

3

Herndon, VA). Human ASC were cultured (37 C, 5% CO2) until reaching

3D-bioplotting Extrusion temperature ( C)

Excess adipose tissue was collected from five female premenopausal
donors (ages 24–36) in accordance with an approved IRB protocol at
UNC Chapel Hill (IRB 04–1622), and hASC were isolated from the tissue as previously described by our lab and others (Bernacki, Wall, &
Loboa, 2008; Bodle et al., 2014). Cells were expanded in CGM comprised of alpha-modified minimal essential medium (α-MEM with L-glu-

Abbreviations: PCL, polycraprolactone; TCP, β-tricalcium phosphate.

tamine; Invitrogen, Carlsbad, CA), 10% fetal bovine serum (FBS;

80% confluency changing the media every 3 days, and then passaged
using trypsin–EDTA (Invitrogen). A superlot was generated by pooling
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equal numbers of cells from the five individual donor cell lines into a

described above, scaffolds were stained in an Alcian blue solution

single culture vessel as previously described by our lab, and character-

(Sigma-Aldrich) for 30 min, washed under running tap water for

ized for multilineage differentiation potential by culturing for 14 days in

2 min, and rinsed with deionized water. Scaffolds were then stained

osteogenic differentiation medium (Minimum Essential Medium, alpha

with 0.1% Nuclear Fast Red (Sigma-Aldrich) for 5 min, tap water

modified supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml

for 1 min.

penicillin, 100 mg/ml streptomycin, 50 μM ascorbic acid, 0.1 μM dexamethasone, and 10 mM β-glycerolphosphate) and adipogenic differentiation

medium

(Minimum

Essential

Medium,

alpha

modified

2.8.3

|

Quantitative RT-PCR

supplemented with 10% FBS, 2 mM L-glutamine, 100 U/ml penicillin,
100 mg/ml streptomycin,1 μM dexamethasone, 5 μg/ml insulin,

Quantitative real-time RT-PCR was used to determine relative mRNA

100 μM indomethacin, and 500 μM isobutylmethylxanthine), ensuring

expression changes of chondrogenic-specific genes in seeded scaffolds

the superlot differentiation was representative of an average of the five

with dECM or without dECM and osteogenic-specific genes seeded

cell lines (Bodle et al., 2014). All experiments were run using superlot

scaffolds with TCP or without TCP (n = 5 per condition). Total RNA was

passage 6 or lower.

extracted directly from the scaffolds after 28 days in culture. Following

To assess osteogenesis, PCL-TCP scaffolds (n = 8) were seeded

the TRIZOL protocol (Thermo Fisher Scientific). Briefly, the scaffolds

with hASC at a density of 250,000 cells per scaffold and incubated for

were submerged in 1 ml of TRIZOL followed by a chloroform (Ricca

28 days in CGM. To assess chondrogenesis, 250,000 hASC in 1 ml of

Chemical Co. Arlington, TX) extraction. The precipitated solution was

CGM were seeded onto each PCL-dECM scaffold (n = 9) and cultured

incubated with an equal volume of isopropanol (Sigma-Aldrich) and 1 μl

for 28 days in CGM (Mellor et al., 2015; Puetzer et al., 2010).

glycoblue (Thermo Fisher Scientific) at room temperature for 10 min.
The solution was centrifuged, and the precipitate was washed once
with 75% ethanol (Koptec) and centrifuged again to collect the RNA

2.7

Osteogenic differentiation assays

|

containing pellet. The RNA was resuspended in DEPC treated water
(Mediatech) and the yield was calculated using a NanoDrop 2000 Spec-

Osteogenic differentiation was assessed via calcium staining and

trophotometer (Sigma-Aldrich). To quantify mRNA expression, 120 ng

endogeonous alkaline phosphatase activity (ALP). Scaffolds were fixed

of total RNA was reverse transcribed into cDNA using a high capacity

for 30 min in formalin at day 28 and stained via Alizarin Red (Sigma-

first strand cDNA synthesis kit (OriGene, Rockville, MD) as per manu-

Aldrich) for calcium accretion. Endogenous ALP activity was assessed

facturer's instructions. qRT-PCR was performed using 1 μl cDNA, 10 μl

at days 14 and 28. Scaffolds were collected in 1 ml RIPA buffer

SYBR Green (Applied Biosystems, Foster City, CA), 7 μl DEPC treated

(Fisher). ALP was quantified with the Alkaline Phosphatase Liquicolor

water (Mediatech), and 1 μl forward and reverse primer (IDT DNA)

Test (Stanbio, Boerne, TX), using the P-nitrophenylphosphate method-

for the following genes: b-actin 5'-CACTCTTCCAGCCTTCCTTC-3', 3'-

ology, as described previously (Bodle et al., 2013). ALP activity was

TGTAGGCGTTTCTGGACATG-5', Osteopontin 50 -CTCAGGCCAGTTG

normalized to total protein content quantified using a Pierce Micro

CAGCC-30 , 30 -CTCTTAACGTCACTAAACGAAAAC-50 ALP 50 -GACCC

BCA Protein Assay Kit (Thermo Fisher Scientific). Additionally, an

TTGACCCCCACAAT-30 , 30 -TCCCCTGTACGTCATGCTCG-50 Collagen1a2

Alamar Blue assay (AbD Serotec, Raleigh, NC) was used to assess met-

50 -AGAGTGGAGCAGTGGTTACTA-30 , 30 -GAGATGACCGCTTTGGAC

abolic activity of the seeded cells at days 14 and 28.

ATAG-50 , Aggrecan 50 -CAGGCAGATCACTTGAGGTTAG-30 , 30 -ACATT
AGGGTCGATGATCCCTC-50 , Sox9 50 -TGACCTATCCAAGCGCATTAC30 , 30 -ATTTGGGAGAAGTCTCGTTCG-50 .

2.8

Chondrogenic differentiation assays

|

qRT-PCR was performed using an ABI 7000 Sequence Detection
system (Applied Biosystems). Samples were assayed in triplicate in

2.8.1

|

Safranin-O staining

one run (40 cycles) per gene. qRT-PCR data were analyzed using the
2−ΔΔCT method as described previously (Livak & Schmittgen, 2001)

Safranin-O staining was used to determine proteoglycan content of

with β-actin as the housekeeping control. Relative quantification

the seeded scaffolds. Scaffolds were fixed in 10% formalin and first

values are presented as fold changes in gene expression relative to

stained with Weigert's Iron Hematoxylin stain (Sigma-Aldrich) for

the control group.

10 min, then rinsed under running tap water. They were then stained
with fast green for 5 min and washed in 1% acetic acid, followed by
an 8 min Safranin-O stain.

2.9 | Fabrication and in vitro hASC culture of
integrated full thickness osteochondral scaffolds

2.8.2

2.9.1

|

Alcian blue staining

|

Electrospun layer fabrication

Alcian Blue staining was used to determine sulfated glycosaminogly-

Electrospun PCL matrices, designed to mimic the function of the tide-

can (sGAG) content of the seeded scaffolds. After fixation as

mark layer, were separately fabricated prior to 3D-bioplotting of the
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full thickness multiphasic scaffold. PCL was dissolved in chloroform
and dimethylformamide (3:1 ratio by volume) to create a 12% solu-

2.11 | Characterization of the effects of
electrospun PCL tidemark matrix

tion. The solution was mixed continuously at 80 C for 4 hr. The PCL
solution was electrospun immediately after preparation at a feed rate

PCL scaffolds were fabricated with (n = 4) or without (n = 4) an

of 0.7 μl/hr using 15 kV and then cut into discs (Ø14.5 mm × 30 μm)

electrospun PCL tidemark matrix to evaluate cell migration character-

to match the 3D-bioplotted scaffolds.

istics. Scaffolds had an overall thickness of 6 mm, and tidemarks were
added to split the scaffolds into 2 and 4 mm sections. Each scaffold
was seeded by suspending 250,000 cells in 150 μl of media in a well

2.9.2

|

Full thickness scaffold assembly

of a 24-well plate for 4 hr with the 2 mm scaffold section facing
downwards into the cell suspension. After 4 hr, the 2 mm section was

The integrated triphasic scaffolds (Ø14.5 x 6 mm) were designed to

flipped upwards in a new 24-well plate and 1 ml of media was added

resemble the overall organization of the osteochondral complex, and

to the scaffold. This yielded a scaffold with the top 2 mm

the manufacturing method used has been described previously

section seeded with cells but the bottom 4 mm section remaining

(Mehendale et al., 2017; Mellor et al., 2017). The material composi-

unseeded. Sterile, nontissue culture treated plates were used to pre-

tion, strand-pore geometries, and process parameters for the bone

vent cells from attaching to the plate. Half media changes were car-

(PCL-TCP), cartilage (PCL-dECM), and tidemark (electrospun PCL)

ried out every other day for 28 days. After 28 days, scaffolds were

phases were as described above. To create the scaffolds in a single

fixed and stained via hematoxylin and eosin (H&E) for cell nuclei and

build, the PCL-TCP phase (Ø14.5 x 4 mm, 12 layers) was bioplotted

protein distribution. The scaffolds were submerged in hematoxylin for

first. Immediately upon completion of the topmost PCL-TCP layer,

10 min, washed under running tap water for 5 min, rinsed in deionized

the process was briefly halted, and the prefabricated electrospun

water, stained via Eosin for 2 min, rinsed in deionized water and

PCL disc (Ø14.5 mm × 30 μm) was overlaid on top of the partial

immediately imaged on an EZ4D histology microscope (Leica, Wetzlar,

scaffold. 3D-bioplotting was then continued with the appropriate

Germany).

height offset adjustment to create the PCL phase (Ø14.5 x 2 mm, six
layers).
A 2-day hASC seeding protocol was used to seed the full

2.12

|

Statistical analyses

thickness scaffolds (n = 3). On the first day, the scaffolds were
sterilized with successive 70% ethanol and PBS washes. The

Statistical analyses were performed using Prism (version 5.0a, Gra-

chondrogenic phase was prepared by submersing the 3D-

phPad Software). Student t test was used to assess significant differ-

bioplotted PCL in neutralized dECM solution and incubating at

ences between two groups, and ANOVA with Tukey post hoc test

37 C for 1 hr. After the hydrogel had solidified, the scaffold was

was used to asses significant differences among three or more groups.

flipped chondrogenic PCL phase up, seeded with 250,000 hASC,

All Graphs are shown in the form of mean ± SEM.

and incubated overnight (37 C, 5% CO2). On the second day, the
scaffolds were flipped PCL-TCP phase up, and seeded with an
additional 500,000 hASC. The total number of cells used in these

3
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scaffolds was tripled in the full osteochondral scaffolds because
they were three times thicker than the individual chondrogenic
and osteogenic scaffolds. Each osteochondral scaffold was incu-

3.1 | PCL–TCP scaffolds-induced osteogenic
differentiation of hASC

bated in 3 ml CGM for 28 days. Media was changed and scaffolds
were flipped every 2 days.

Controlled release assays of calcium demonstrated that calcium was
released from the PCL-TCP composite scaffolds throughout the
28 day incubation period, with a large initial release within the first

2.10 | Characterization of full thickness
osteochondral scaffolds

24 hr (Figure 2a).
To determine how the calcium released from the scaffolds
affected the seeded hASC, assays were performed to assess osteo-

After 28 days of culture, full thickness scaffolds (n = 3 unseeded, n = 3

genic differentiation. Enzymatic ALP activity, a hallmark of osteogenic

seeded) were fixed for 30 min in formalin. Total scaffold fixation and

differentiation (Bodle et al., 2013), was elevated PCL-TCP composi-

staining has been utilized previously to demonstrate calcium distribu-

tion scaffolds when compared to pure PCL scaffolds (Figure 2b). This

tion in bone scaffolds (Lu et al., 2017; Ma et al., 2014). Scaffolds were

trend was observed at both the 14 (p = .115) and 28-day (p = .073)

sectioned with a scalpel into 1 mm thick cross-sections for histological

time points. At the gene expression level, ALP mRNA expression was

analyses. Sections were stained via Alizarin Red, Alcian Blue, and

elevated in PCL-TCP scaffolds at day 14 (p = .323), but was reduced

Safranin-O/fast green, as described above.

relative to the control by day 28 (*p = .018; Figure 2c). Osteopontin
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F I G U R E 2 Osteogenesis of hASC on 3D-bioplotted PCL-TCP scaffolds. (a) The calcium release profile of osteogenic scaffolds (20% TCP 80%
PCL) evaluated over 28 days (bars represent standard error of the mean; different letters indicate statistical difference [p < .05]). (b) Endogenous
ALP activity of seeded scaffolds at both the 14 and 28 day time points. Gene expression of (c) ALP and (d) Osteopontin. (e) Alizarin Red staining
indicated calcium accretion (scale bars = 200 μm). (f) Alamar Blue data indicating metabolic activity at days 14 and 28 of culture (***p < .001,
*p < .05). ALP, alkaline phosphatase; hASC, human adipose-derived stem cells; PCL, polycraprolactone; TCP, β-tricalcium phosphate

was elevated in PCL-TCP at day 14 (*p < .001; Figure 2d). End prod-

ECM proteins were preserved after the decellularization process

uct calcium staining demonstrated that hASC cultured on PCL-TCP

(Pu & Oxford, 2015; Figure 3). We identified 775 unique peptides

scaffolds accreted calcium while hASC cultured on PCL scaffolds

corresponding to proteoglycans, collagens, and other ECM proteins.

alone did not accrete calcium. Acellular PCL-TCP controls showed

Figure 3 shows the relative abundances of the most prevalent

mild Alizarin Red staining due to the TCP found within the scaffold,

proteins.

but seeded PCL-TCP stained dark red throughout the scaffold, indi-

Human ASC were then seeded on 3D-bioplotted scaffolds with

cating hASC-mediated calcium accretion (Figure 2e). Scaffolds without

or without dECM and evaluated for chondrogenic differentiation. His-

TCP showed no Alizarin Red staining.

tological staining showed more robust proteoglycan (Safranin-O) and

We have previously demonstrated that bioplotted PCL scaffolds

sGAG (Alcian Blue) staining in scaffolds that were seeded when com-

support viability and proliferation of hASC (Mehendale et al., 2017;

pared to their unseeded controls, even in the absence of dECM

Mellor et al., 2017). To assess the cell viability and proliferation within

(Figure 4). Unseeded scaffolds without dECM did not stain for either

the current study, Alamar Blue was used to detect metabolic activity

proteoglycan or sGAG content, as expected. Moderate matrix deposi-

of the seeded cells (Figure 2f). In this assay, a higher percent reduc-

tion was observed on the hASC seeded scaffolds without dECM,

tion corresponds to higher metabolic activity of the assayed cells. On

while the unseeded scaffolds with a dECM coating stained positive

both pure PCL scaffolds and PCL-TCP composite scaffolds, metabolic

for proteoglycan or sGAG from the dECM itself. The unseeded dECM

activity increased between days 14 and 28, which suggests continued

had regions of degradation and lacked organization. Seeded scaffolds

proliferation of the cells throughout the 4-week culture period. Meta-

with dECM coating had an evenly distributed matrix that had under-

bolic activity was higher in PCL-TCP composite scaffolds than in pure

gone remodeling from the cells. In addition, qualitative observation of

PCL scaffolds at both time points.

the scaffolds showed that more matrix was deposited on the dECM
seeded scaffolds than the unseeded scaffolds, indicating end product
accretion

3.2 | PCL-dECM scaffolds-induced chondrogenic
differentiation of hASC

of

chondrogenic

differentiation.

Human

ASC

cho-

ndrogenesis was further evaluated by qPCR with similar results
(Figure 4m–o). Although no statistical significance was observed in
this data set, the following trends were observed. Seeded PCL-dECM

The dECM hydrogel used to induce hASC chondrogenic differentia-

scaffolds exhibited increased expression of sox9, an early marker of

tion was analyzed using proteomic analysis to ensure that the primary

chondrogenic differentiation (Kawakami, Rodriguez-Leon, & Izpisua
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F I G U R E 3 Proteomic analysis of decellularized bovine cartilage extracellular matrix (dECM). Proteomic analysis of the dECM identified
several cartilage proteins based on 775 unique peptides from articular cartilage. Proteoglycans: The most prevalent include fibromodulin, biglycan,
PRELP, chondroadherin, decorin, aggrecan, link protein, lumican, and perlecan. Collagens: The most prevalent identified include COL2A1,
COL6A3, COL9A1, COL12A1, COL6A2, COL6A1, COL15A1, COL11A2, and COL11A1. Noncollagenous ECM proteins: The most prevalent
include fibronectin, Cartilage Oligomeric Matrix Protein (COMP), matrilin 3 (MATN3), cartilage intermediate layer protein 2 (CILP2), tenascin C
(TNC), thrombospondin type 1 (THBS1), thrombospondin type 4 (THBS4), and clusterin

Belmonte, 2006). After 28 days in culture, aggrecan expression in

region of the scaffold stained dark red with the Alizarin Red staining,

PCL-dECM scaffolds was elevated. Furthermore, Collagen I expres-

indicating calcium accretion within this region of the scaffold. The

sion in dECM coated scaffolds was reduced relative to hASC seeded

PCL-dECM portion of the scaffold stained with Safranin-O indicated

on non-dECM scaffolds at day 14 but elevated at day 28.

the presence of proteoglycans, and Alcian Blue indicated the presence
of sGAG. Alizarin Red, Alcian Blue, and Safranin-O staining was more
robust in the hASC seeded scaffolds than the nonseeded controls,

3.3 | Full thickness osteochondral scaffolds
exhibited site-specific tissue differentiation

demonstrating that end-product expression rather than the biomimetic nature of the scaffolds themselves contributed to at least part
of the observed staining patterns. In addition, the bone-like portion of

Histological staining of the full-thickness scaffolds revealed site-

the scaffold and cartilage-like portion of the scaffold transitioned

specific osteochondral tissue characteristics (Figure 5). The PCL-TCP

cleanly from one phase to the other at the electrospun tide mark.
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F I G U R E 4 Chondrogenic evaluation of 3D-bioplotted PCL-dECM scaffolds. (a–d) Unstained scaffolds of each condition (e–h). Scaffolds
stained for proteoglycan content via Safranin-O. (i–l) Scaffolds stained for sulfated glycosaminoglycans content via Alcian Blue (scale
bars = 200 μm). Gene expression of (m) sox9 and (n) aggrecan, and (o) collagen I. dECM, decellularized bovine cartilage extracellular matrix; PCL,
polycraprolactone

3.4 | The electrospun tidemark prevents cell
migration

staining on the seeded side of the scaffolds and reduced cell
nuclear and protein staining on the nonseeded side. However,
scaffolds that did not include a tidemark had much more homoge-

H&E staining of scaffolds that were cultured with and without an

nous cell distribution throughout the scaffold. The scaffolds with-

electrospun layer to mimic a osteochondral tidemark displayed

out an electrospun layer had a greater density of nuclei on the

different cell distributions (Figure 6). Scaffolds that included a

nonseeded side of the scaffold than the scaffolds that contained

tidemark displayed much more robust nuclear and protein

an electrospun layer.
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F I G U R E 5 Site-specific matrix distribution in full-thickness osteochondral scaffolds. (a,b) Alizarin red shows calcium deposition in the osteo
layer, while (c,d) Alcian Blue and (e,f) Safranin-O staining demonstrate increased proteoglycan and sulfated glycosaminoglycans in the superficial
cartilage layer (scale bars = 2 mm)

F I G U R E 6 Gross comparison of
scaffolds stained via hematoxylin and
eosin shows that (a) scaffolds without an
electrospun tidemark have relatively
homogenous cellular distribution.
(b) Scaffolds that contain an electrospun
tidemark have more robust staining on
the seeded side when compared to the
nonseeded side of the scaffold. Higher
magnification of the far nonseeded sides
of the scaffolds demonstrates that more
nuclei (arrows) are observed on the
(c) scaffolds with no electrospun tidemark
when compared to the (d) scaffolds
containing an electrospun tidemark (scale
bars = a,b: 2 mm, c,d: 400um)
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|

DISCUSSION

crucial extracellular proteins of articular cartilage are preserved after
the decellularization step. We used this naturally derived hydrogel to

The objective of this study was to develop a tissue engineered

direct chondrogenic differentiation of hASC, even in the absence of

osteochondral construct that closely resembled the native architec-

supplemental chondrogenic growth factors. This is in accordance with

ture of osteochondral tissue using a single cell source of abundant and

previous

accessible hASC. A triphasic scaffold was created by combining two

mesencyhmal stem cells can be shunted down the chondrogenic line-

commonly used techniques (electrospinning and 3D printing), and

age via stimulation with cartilage fragments without the use of growth

incorporating chemical cues within the different layers of the scaffold

factors (Chen et al., 2012). Additionally, in this study, we demonstrate

to induce site-specific osteogenic and chondrogenic differentiation of

that hASC have a synergistic effect with the dECM. We observe that

the hASC. Specifically, TCP was used to induce osteogenic differentia-

seeded dECM displayed more robust proteoglycan and sGAG than

tion and dECM was used to induce chondrogenic differentiation.

the nonseeded dECM. Upon closer examination of the histology, the

literature,

that

demonstrated

bone

marrow-derived

TCP has previously been shown to drive osteogenic differentiation

seeded dECM appeared to have been remodeled and augmented by

(Asli, Pourdeyhimi, & Loboa, 2012; McCullen, Zhan, Onorato,

the hASC whereas the nonseeded dECM suffered from degradation.

Bernacki, & Loboa, 2010; Mellor et al., 2015). It has been demonstrated

This indicates that while the dECM is driving chondrogenic differenti-

to induce differentiation in both 2D culture and 3D electrospun con-

ation, the cells are simultaneously modifying the structural properties

structs (McCullen et al., 2010). More recently, we demonstrated that

of the dECM. The results from both dECM and TCP studies drove the

polylactic acid nanofibrous scaffolds containing 20% TCP nanoparticles

development of single osteochondral scaffolds, which can be cultured

drove osteogenic differentiation of hASC and that elevated calcium

in

inhibited chondrogenic differentiation, even in the presence of

chondrogenic growth factors) to induce both hASC chondrogenesis

chondrogenic growth factors (Mellor et al., 2015). Here, we confirm

and osteogenesis in desired site-specific locations.

CGM

alone

(without

any

additional

osteogenic

and/or

that scaffolds containing 20% TCP drive cells to differentiate down the

A novel aspect of our triphasic design was the incorporation of a

osteogenic lineage by demonstrating that osteogenic markers are

thin eletropsun PCL layer between the osteogenic and chondrogenic

upregulated and end product calcium accretion is enhanced in the pres-

layers to mimic the natural tidemark found in osteochondral tissue.

ence of TCP. When compared to previously reported electrospun scaf-

When engineering osteochondral implants, it is a concern that the

folds containing TCP, calcium is released at a much slower rate from

neo-cartilage would ossify if implanted in vivo long term (Benders

the 3D-bioplotted PCL-TCP scaffolds. Specifically, we have previously

et al., 2013). The incorporation of the electrospun tidemark layer is

demonstrated a burst release of 50% calcium within the first 24 hr in

important because it prevents cell migration between the cartilage

electrospun scaffolds (Asli et al., 2012). Here, we only witnessed a

and bone layers. The in vitro results of this study indicate that hASC

release of 0.54 μg (4.5% of total Ca2+) with the first 24 hr, and a

migration is inhibited in scaffolds that include an electrospun layer.

sustained release over the course of 28 days. Even after 28 days, only

This layer could potentially act as a barrier to prevent blood vessel

1.04 μg (8.7% of total Ca ) had been released from the scaffolds,

invasion into the cartilage layer when implanted in vivo.

2+

suggesting that calcium-based signaling would be sustained long term

Since the overall objective of this study was to generate an

in hASC seeded upon these scaffolds, which could be favorable for

osteochondral implant with site-specific characteristics, the global pro-

implantation of the tissue engineered constructs in vivo.

tein and calcium distributions within the 3D multiphasic scaffolds were

The cartilage layer of the 3D-bioplotted scaffold was coated with

assessed. The scaffolds were cultured for 4 weeks, which gave the bio-

cartilage dECM in order to drive chondrogenic differentiation of the

active factors and cells seeded upon those layers ample time to interact

hASC without the need of growth factor supplementation. In recent

with each other. Since both the osteogenic side and chondrogenic side

years, there has been great interest in the use of dECM for

were cultured simultaneously within the same dish, interactions

osteochondral tissue engineering (Benders et al., 2013). Since natu-

between the two phases cannot be avoided, and we did not attempt to

rally derived ECM has a complex array of bioactive molecules, it is

mitigate these interactions. Since bone and cartilage are known to

ideal to signal cells to adhere (Tavassoli, Matin, Niaki, Mahdavi-

crosstalk extensively in vivo (Funck-Brentano & Cohen-Solal, 2011), this

Shahri, & Shahabipour, 2015), proliferate (Vorotnikova et al., 2010),

mimics native osteochondral signaling. Staining revealed that site-

and differentiate (Gong, Sagiv, Cai, Tsang, & Del Priore, 2008; Sellaro,

specific characteristics within the 3D architecture are maintained

Ravindra, Stolz, & Badylak, 2007). In cartilage tissue engineering, the

throughout the duration of the culture, despite these interactions.

use of a bioactive biomaterial is especially useful since cartilage is

Although the current study presents a novel system for producing

avascular and cannot easily circulate growth factors and nutrients

site-specific differentiation of hASC within a single scaffold, a limita-

(Benders et al., 2013). Previously, biphasic osteochondral scaffolds

tion of the current study is that only in vitro characterization was per-

have been produced via combination of decellularized cartilage and

formed. Although in vitro characterization is an essential step before

decellularized bone (Yang et al., 2011). In addition, monophasic dec-

moving into animal models, this scaffold system will require in vivo

ellularized equine cartilage matrix implants have been used to gener-

validation in future studies. Specifically, in order to assess the poten-

ate

potential

tial for large scale preclinical studies and eventual clinical translation,

vascularization and ossification of the neo-cartilage is a concern

this scaffold system must be validated in a large animal model to

(Benders et al., 2013). In this study, we demonstrate that most of the

ensure that the scaffold does not elicit an immune response and

biphasic

osteochondral

regeneration,

although
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achieves the desired healing in vivo (Cook et al., 2014). Additionally,
for this study we use decellularized porcine ECM as it is easily obtainable and is amenable to future porcine in vivo studies. However, for
clinical purposes, large amounts of human cartilage will be more difficult to obtain, and therefore an immune response to porcine tissue
will have to be considered. Although the tissue is decellularized and
sterilized, further studies to assess cross-species immune response
will be necessary prior to clinical studies.
This study is the first to incorporate TCP and dECM in a single 3Dbioplotted scaffold to induce site-specific differentiation of hASC as a single cell source to generate a full osteochondral construct. Recent research
in osteochondral scaffold fabrication has utilized 3D printing approaches
to generate patient-specific scaffolds in a precise and highly tunable manner. In this study, we take advantage of recent advances in biofabrication
to generate scaffolds that are thick enough to repair full-thickness
osteochondral defects, unlike electrospun scaffolds. We show, for the first
time, that the incorporation of an electrospun layer can inhibit cell migration between scaffold layers, which may be highly advantageous in vivo
by preventing blood vessels from invading the chondrogenic portion of
the scaffold. The scaffold design described in this study minimizes rejection by using an abundant and accessible source of autologous stem cells,
and our biofabrication techniques allow for a precise, customizable methodology to rapidly produce the scaffold. With further development, this
novel approach could hold great potential to treat OA patients by offering
a patient-specific, less-invasive alternative to full joint replacement.
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